Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

CATX holding history

Perspective Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CATX overviewAll 13F holders of CATXFull Q2 2026 holdings

Shares (Q2 2026)
3,805,739
Value
$13.0M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of CATX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,805,739$13.0M<0.1%+239,235+6.7%AddedHolders
Q1 20263,566,504$14.9M<0.1%+3,296,013+1,218.5%AddedHolders
Q4 2025270,491$743.9K<0.1%+109,830+68.4%AddedHolders
Q3 2025160,661$551.1K<0.1%+116,201+261.4%AddedHolders
Q2 202544,460$152.9K<0.1%−463,628−91.2%ReducedHolders
Q1 2025508,088$1.08M<0.1%+293,310+136.6%AddedHolders
Q4 2024214,778$685.1K<0.1%+202,754+1,686.2%AddedHolders
Q3 202412,024$160.5K<0.1%−563,525−97.9%ReducedHolders
Q2 2024575,549$5.74M<0.1%−11,691,883−95.3%ReducedHolders
Q1 202412,267,432$14.6M<0.1%+12,267,432NewHolders
Q3 20230$00.0%−166,779−100.0%Sold outHolders
Q2 2023166,779$111.4K<0.1%+166,779NewHolders
Q1 20230$00.0%−305,635−100.0%Sold outHolders
Q4 2022305,635$75.5K<0.1%+279,730+1,079.8%AddedHolders
Q3 202225,905$6.00K<0.1%−15,115−36.8%ReducedHolders
Q2 202241,020$13.0K<0.1%−85,920−67.7%ReducedHolders
Q1 2022126,940$46.0K<0.1%+126,940NewHolders
Q4 20210$00.0%−10,798−100.0%Sold outHolders
Q3 202110,798$7.00K<0.1%−40,548−79.0%ReducedHolders
Q2 202151,346$41.0K<0.1%−70,988−58.0%ReducedHolders
Q1 2021122,334$134.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.